Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Y-4 vs Pregabalin and Riluzole in Healthy Subjects
NCT06935721Phase 1Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Mar 2025
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of Y-4 in neuropathic pain (3 arms), sponsored by Beijing Tiantan Hospital. Primary endpoints: Adverse Events, Incidence of abnormal laboratory test results and 3 more. Started Mar 2025; status: recruiting.
02
Drugs
Y-4
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT06935721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06935721.